Press Release Jun 10 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report for its API manufacturing facility at Dabhasa. The facility was inspected by the USFDA and classified as Voluntary Action Indicated, with the inspection confirmed as closed. This announcement serves as a disclosure in accordance with regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jun 02 2025
- Press Release May 28 2025
- Press Release May 23 2025
- Press Release May 20 2025
- Press Release May 14 2025
Later from Zydus Lifesciences
- Press Release Jun 11 2025
- Press Release Jun 18 2025
- Press Release Jul 15 2025
- Press Release Jul 16 2025
- Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences